Centralized Review Process Markedly Expedites Approval of Cancer Clinical Trials
Monday, October 19, 2009 - 18:35
in Health & Medicine
(PhysOrg.com) -- A Central Institutional Review Board (CIRB) for cancer clinical trials that was created by the National Cancer Institute (NCI), part of the National Institutes of Health, in 2001 helps trials start more quickly (just over a month faster, on average) and thus expedite the time from concept to completion of crucial investigational research according to a new finding. This study of the CIRB was performed by scientists at the Veterans Affairs Palo Alto Health Care System (VAPAHCS) and Stanford University School of Medicine, Palo Alto, Calif., with assistance from NCI and appears online October 19, 2009 in the Journal of Clinical Oncology.
Read the whole article on Physorg
More from Physorg
Related
- National call for cancer clinical trial system to be more responsive to community needsTue, 11 Nov 2008, 12:53:49 EST
- Project Zero Delay accelerates drug's path to clinical trialMon, 3 Aug 2009, 16:24:58 EDT
- Quality assurance programs improve clinical trialsSun, 21 Sep 2008, 17:22:15 EDT
- Results from TH-302 clinical trials presented at international lung cancer meetingThu, 6 Aug 2009, 17:30:56 EDT
- Veterinary oncologists advance cancer drugs for humans and petsWed, 15 Apr 2009, 16:22:32 EDT